PMID- 19920778 OWN - NLM STAT- MEDLINE DCOM- 20091203 LR - 20211028 IS - 1534-6080 (Electronic) IS - 0041-1337 (Linking) VI - 88 IP - 6 DP - 2009 Sep 27 TI - Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. PG - 791-8 LID - 10.1097/TP.0b013e3181b4a9ff [doi] AB - BACKGROUND: Knowledge of the human leukocyte antigen (HLA) amino acid (AA) sequence combined with crystallographic structural data may enable prediction of the relative immunogenicity of individual donor/recipient HLA mismatches. METHODS: Multiple sera from 32 highly sensitized patients awaiting kidney transplantation were screened using Luminex/single-antigen beads to determine the HLA-specific antibody levels against mismatched HLA class I specificities. A computer program was developed to allow intralocus and interlocus comparison of mismatched HLA-A and -B specificities with corresponding recipient HLA class I type, and to determine the number, position, and physiochemical disparity (hydrophobicity and electrostatic charge) of polymorphic AA. RESULTS: HLA-specific antibody was detected against 1666 (85%) of the 1964 mismatched HLA specificities evaluated, with a close correlation between increasing number of AA polymorphisms and the presence and magnitude of the alloantibody response (P<0.0001). Hydrophobicity and electrostatic charge disparity scores were independent predictors of alloantibody production (adjusted P=0.0009 and P=0.0005, respectively). Mismatched specificities with physiochemical scores within the first decile of the scale led to weak alloantibody responses (median fluorescence intensity 2330), whereas those with scores above the sixth decile led to strong alloantibody production (median fluorescence intensity >10,000). CONCLUSION: Differences in AA number, hydrophobicity, and electrostatic charge between HLA class I specificities enable prediction of donor HLA class I types with low immunogenicity for a given recipient. FAU - Kosmoliaptsis, Vasilis AU - Kosmoliaptsis V AD - Tissue Typing Laboratory, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, England. FAU - Chaudhry, Afzal N AU - Chaudhry AN FAU - Sharples, Linda D AU - Sharples LD FAU - Halsall, David J AU - Halsall DJ FAU - Dafforn, Timothy R AU - Dafforn TR FAU - Bradley, J Andrew AU - Bradley JA FAU - Taylor, Craig J AU - Taylor CJ LA - eng GR - MC_U105232027/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Transplantation JT - Transplantation JID - 0132144 RN - 0 (Amino Acids) RN - 0 (HLA Antigens) RN - 0 (HLA-A Antigens) RN - 0 (HLA-B Antigens) RN - 0 (HLA-C Antigens) RN - 0 (Immunoglobulin G) RN - 0 (Isoantibodies) SB - IM CIN - Transplantation. 2009 Sep 27;88(6):760-1. PMID: 19920773 MH - Adult MH - Aged MH - Amino Acids/chemistry/genetics MH - Female MH - HLA Antigens/*chemistry/classification/*genetics MH - HLA-A Antigens/chemistry/genetics MH - HLA-B Antigens/chemistry/genetics MH - HLA-C Antigens/chemistry/genetics MH - Histocompatibility Testing/statistics & numerical data MH - Humans MH - Hydrophobic and Hydrophilic Interactions MH - Immunochemistry MH - Immunoglobulin G/blood MH - Isoantibodies/blood MH - Kidney Transplantation/immunology MH - Male MH - Middle Aged MH - *Polymorphism, Genetic MH - Software MH - Static Electricity MH - Tissue Donors MH - Transplantation Immunology EDAT- 2009/11/19 06:00 MHDA- 2009/12/16 06:00 CRDT- 2009/11/19 06:00 PHST- 2009/11/19 06:00 [entrez] PHST- 2009/11/19 06:00 [pubmed] PHST- 2009/12/16 06:00 [medline] AID - 00007890-200909270-00009 [pii] AID - 10.1097/TP.0b013e3181b4a9ff [doi] PST - ppublish SO - Transplantation. 2009 Sep 27;88(6):791-8. doi: 10.1097/TP.0b013e3181b4a9ff.